Skip to main content
Premium Trial:

Request an Annual Quote

'Now is the Time'

John Holdren, director of the Obama administration's Office of Science and Technology Policy, recently testified in front of Congress on the science budget, says The Intersection's Chris Mooney. Holdren told Congress that while the Obama administration is committed to reducing the budget and the deficit, it is also dedicated to "prim[ing] the pump of discovery and innovation" by proposing increased investments in research and STEM education. "America's strength, prosperity, and global leadership depend directly on the investments we're willing to make in R&D, in STEM education, and in infrastructure," Holdren told Congress. This is exactly the right attitude to take, Mooney says. When times are tough economically, it's important to increase investment in research and innovation, not cut it, he says, adding, "In hard times, you don't give up on vision. You knuckle down, sure, but you also look ahead."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.